Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
ClinicalTrials.gov study NCT00773734. IPD Sharing: Not stated. Countries: 2. Publications: 8.
Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis
ClinicalTrials.gov study NCT00041756. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01186744. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
ClinicalTrials.gov study NCT00698646. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis
ClinicalTrials.gov study NCT01988103. IPD Sharing: YES. Countries: 1. Publications: 3.
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
ClinicalTrials.gov study NCT01620489. IPD Sharing: Not stated. Countries: 6. Publications: 4.
A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis
ClinicalTrials.gov study NCT03090100. IPD Sharing: Not stated. Countries: 9. Publications: 4.
A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
ClinicalTrials.gov study NCT01895309. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exa
ClinicalTrials.gov study NCT02130193. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02576678. IPD Sharing: YES. Countries: 4. Publications: 1.
Moderate Alcohol and Cardiovascular Health Trial
ClinicalTrials.gov study NCT03169530. IPD Sharing: NO. Countries: 3. Publications: 1.
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02958865. IPD Sharing: YES. Countries: 19. Publications: 4.
A Study in Japanese Participants With Moderate-to-Severe Psoriasis
ClinicalTrials.gov study NCT01624233. IPD Sharing: YES. Countries: 1. Publications: 2.
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
ClinicalTrials.gov study NCT02357420. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
ClinicalTrials.gov study NCT03242252. IPD Sharing: NO. Countries: 16. Publications: 1.
Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
ClinicalTrials.gov study NCT02921555. IPD Sharing: NO. Countries: 1. Publications: 16.
Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
ClinicalTrials.gov study NCT00940589. IPD Sharing: Not stated. Countries: 3. Publications: 2.
A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne
ClinicalTrials.gov study NCT03124381. IPD Sharing: NO. Countries: 1. Publications: 9.
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03466411. IPD Sharing: Not stated. Countries: 43. Publications: 4.
Mild, Moderate and Severe Renal Impairment Study
ClinicalTrials.gov study NCT02219516. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.